United States · FDA National Drug Code directory
Cyclophosphamide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65219-133_fadfc813-11a5-415a-9d70-06c579e7619c
- Product NDC
- 65219-133
- Form
- INJECTION, POWDER, FOR SOLUTION
- Composition / generic term
- cyclophosphamide
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231117
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOPHOSPHAMIDE — 2 g/100mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (65219-133-20) / 100 mL in 1 VIAL, SINGLE-DOSE · 65219-133-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →